Veradermics, Inc (MANE) KPIs and segments

MANENYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30

$135.29−21.27 (-13.59%)

Close on Nov 12, 2026Market cap $5.65BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Veradermics's business

Coming soon

This tab will track the numbers specific to Veradermics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?